Exhibits
20-F
from 20-F
96 pages
20-F
03/03/22
EX-1.1
from 20-F
13 pages
Corporate Access Number: 207797382 Government of Alberta Business Corporations Act Certificate of Amendment Oncolytics Biotech Inc. Amended Its Articles on 20 18/05/22. Name/Structure Change Alberta Corporation - Registration Statement Alberta Amendment Date: 2018/05/22 Service Request Number: 29037579 Corporate Access Number: 207797382 Legal Entity Name: Oncolytics Biotech Inc. French Equivalent Name: Legal Entity Status: Active Alberta Corporation Type: Named Alberta Corporation New Legal Entity Name: Oncolytics Biotech Inc. New French Equivalent Name: Nuans Number: 60651958 Nuans Date: 1998/04/06 French Nuans Number: French Nuans Date: Share Structure: Schedule “A” Share Transfers Restrictions: None. Number of Directors: MM Number of Directors: 3 Max Number of Directors: 11 Business Restricted To: None Business Restricted From: None Other Provisions: See Attached Schedule of Other Provisions. Bca Section/Subsection: Section 173(1)(f) Professional Endorsement Provided: Future Dating Required: Annual Return Ifi1e Yearlldate Filed I 120 17 12017/05/081 [2016 Ij6/O5/O9l 2015 12016/03/181 Attachment
03/03/22
EX-1.2
from 20-F
7 pages
Division One Interpretation Division Two Directors
03/03/22
EX-2.1
from 20-F
1 page
Description of Rights of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 Our Authorized Capital Consists of an Unlimited Number of Common Shares. the Following Is a Summary of the Provisions Attached to Our Common Shares
03/03/22
EX-4.18
from 20-F
2 pages
Amending Agreement #3
03/03/22
EX-4.19
from 20-F
2 pages
Amending Agreement #3
03/03/22
EX-4.20
from 20-F
2 pages
Amending Agreement
03/03/22
EX-4.21
from 20-F
2 pages
Amending Agreement #5
03/03/22
EX-4.22
from 20-F
3 pages
Amending Agreement #2
03/03/22
EX-8.0
from 20-F
1 page
Subsidiaries
03/03/22
EX-12.1
from 20-F
1 page
Management certification
03/03/22
EX-12.2
from 20-F
1 page
Management certification
03/03/22
EX-13.1
from 20-F
1 page
Management certification
03/03/22
EX-13.2
from 20-F
1 page
Management certification
03/03/22
EX-15.1
from 20-F
28 pages
Additional exhibits
03/03/22
EX-15.2
from 20-F
1 page
Additional exhibits
03/03/22
Graphics & Data Files
GRAPHIC
from 20-F
articles001.jpg
03/03/22
GRAPHIC
from 20-F
articles002.jpg
03/03/22
GRAPHIC
from 20-F
articles003.jpg
03/03/22
GRAPHIC
from 20-F
articles004.jpg
03/03/22
GRAPHIC
from 20-F
articles005.jpg
03/03/22
GRAPHIC
from 20-F
articles006.jpg
03/03/22
GRAPHIC
from 20-F
articles007.jpg
03/03/22
GRAPHIC
from 20-F
articles008.jpg
03/03/22
GRAPHIC
from 20-F
articles009.jpg
03/03/22
GRAPHIC
from 20-F
articles010.jpg
03/03/22
GRAPHIC
from 20-F
articles011.jpg
03/03/22
GRAPHIC
from 20-F
articles012.jpg
03/03/22
GRAPHIC
from 20-F
oncolyticslogotaglinebluea.jpg
03/03/22
GRAPHIC
from 20-F
oncyf-20211231_g1.jpg
03/03/22
GRAPHIC
from 20-F
oncyf-20211231_g2.jpg
03/03/22
GRAPHIC
from 20-F
oncyf-20211231_g3.jpg
03/03/22
GRAPHIC
from 20-F
eyheadera.jpg
03/03/22
